These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9616538)

  • 21. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
    Ulrik CS
    Thorax; 1995 Jul; 50(7):750-4. PubMed ID: 7570409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxitropium bromide improves exercise performance in patients with COPD.
    Ikeda A; Nishimura K; Koyama H; Sugiura N; Izumi T
    Chest; 1994 Dec; 106(6):1740-5. PubMed ID: 7988193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
    Cazzola M; Calderaro F; Califano C; Di Pema F; Vinciguerra A; Donner CF; Matera MG
    Eur J Clin Pharmacol; 1999 Jan; 54(11):829-33. PubMed ID: 10027655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
    Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
    Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tiotropium bromide: a novel once-daily anticholinergic bronchodilator for the treatment of COPD.
    Hansel TT; Barnes PJ
    Drugs Today (Barc); 2002 Sep; 38(9):585-600. PubMed ID: 12582447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled study.
    Centanni S; Santus P; Casanova F; Carlucci P; Boveri B; Castagna F; Di Marco F; Cazzola M
    Respir Med; 2002 Mar; 96(3):137-41. PubMed ID: 11905547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol.
    Donohue JF; van Noord JA; Bateman ED; Langley SJ; Lee A; Witek TJ; Kesten S; Towse L
    Chest; 2002 Jul; 122(1):47-55. PubMed ID: 12114338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial).
    Bellia V; Foresi A; Bianco S; Grassi V; Olivieri D; Bensi G; Volonté M;
    Respir Med; 2002 Nov; 96(11):881-9. PubMed ID: 12418585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of inhaled oxitropium and fenoterol, alone and in combination, in chronic airflow obstruction.
    Frith PA; Jenner B; Atkinson J
    Respiration; 1986; 50 Suppl 2():294-7. PubMed ID: 3563116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
    Aaron SD; Vandemheen KL; Fergusson D; Maltais F; Bourbeau J; Goldstein R; Balter M; O'Donnell D; McIvor A; Sharma S; Bishop G; Anthony J; Cowie R; Field S; Hirsch A; Hernandez P; Rivington R; Road J; Hoffstein V; Hodder R; Marciniuk D; McCormack D; Fox G; Cox G; Prins HB; Ford G; Bleskie D; Doucette S; Mayers I; Chapman K; Zamel N; FitzGerald M;
    Ann Intern Med; 2007 Apr; 146(8):545-55. PubMed ID: 17310045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease.
    Appleton S; Jones T; Poole P; Pilotto L; Adams R; Lasserson TJ; Smith B; Muhammad J
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006101. PubMed ID: 16856113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease.
    McCrory DC; Brown CD
    Cochrane Database Syst Rev; 2002; 2003(4):CD003900. PubMed ID: 12519615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
    Bateman ED; van Dyk M; Sagriotis A
    Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of salmeterol xinafoate in the treatment of COPD.
    Mahler DA; Donohue JF; Barbee RA; Goldman MD; Gross NJ; Wisniewski ME; Yancey SW; Zakes BA; Rickard KA; Anderson WH
    Chest; 1999 Apr; 115(4):957-65. PubMed ID: 10208192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.
    Cazzola M; Vinciguerra A; Di Perna F; Matera MG
    Respir Med; 1998 Aug; 92(8):1012-6. PubMed ID: 9893768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD.
    Di Marco F; Milic-Emili J; Boveri B; Carlucci P; Santus P; Casanova F; Cazzola M; Centanni S
    Eur Respir J; 2003 Jan; 21(1):86-94. PubMed ID: 12570114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response study of oxitropium bromide inhaled as a nebulised solution.
    Stappaerts I; Van Schil L; Van der Veken J
    Eur J Clin Pharmacol; 1994; 46(4):305-7. PubMed ID: 7957513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.